Epi Alumni Stories

Tushar Singh (EPI '14) awarded 2021 Early Career Excellence Award in recognition of significant achievements early in an alumnus or alumna's career.   

KDKA RADIO – Alex Sundermann (IDM ‘14, EPI ‘22) explains that one in thirty patients gets at least one health care-associated infection – one acquired while in the hospital. “Typical tests see what type of organism it is but that test doesn’t tell you, was it transmitted from a patient or from somewhere in the environment? [Genome surveillance is] like fingerprinting for that test – who has that same organism and who is transmitting to who when ... 

PITTSBURGH POST-GAZETTE - In a recent Op-Ed from Mary Ganguli (EPI '87) says, "We all know there’s just too much information out there: some of it changing over time, some of it well-intended but misguided and some of it deliberate misinformation. It can be confusing and overwhelming. As a medical doctor and professor of epidemiology at the University of Pittsburgh, I’d like to try to cut through that confusion."   

NEW YORK TIMES - In a  study  published on a preprint server in August that has not yet been peer-reviewed, researchers from the University of Pittsburgh used mathematical modeling to predict how severe the upcoming flu season might be based on this increased susceptibility. They reported that if flu and flu vaccination levels are typical of prior years, 102,000 more Americans than average could be hospitalized with influenza — a 20 percent incr... 

AP - “For athletes in particular, their livelihood is based on their ability to compete,” said EPI’s Wendy King (EPI '04), who took part in a research project on vaccine hesitancy earlier this year. “Even if they thought, ‘Oh, I’m pretty healthy and I wouldn’t get that bad of a case,’ it would still heavily impact their ability to go to work, to play in a game. It could affect their entire team — not just them — so they might feel like they’re l... 

PITTSBURGH POST-GAZETTE - An op-ed from Mary Ganguli (EPI '87): Imagine that your doctor has just told that you most likely have Alzheimer’s disease, an incurable type of dementia. And then you see on the news that the U.S. Food and Drug Administration (FDA) has approved a new drug for Alzheimer’s disease called aducanumab, made by a company called Biogen. But, you also read, many doctors oppose the FDA decision. Why would anyone oppose a drug f...